BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17207828)

  • 1. The search of the target of promotion: Phenylbenzoate esterase activities in hen peripheral nerve.
    Moretto A; Nicolli A; Lotti M
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):196-201. PubMed ID: 17207828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy.
    Gambalunga A; Pasqualato F; Lotti M
    Chem Biol Interact; 2010 Sep; 187(1-3):340-3. PubMed ID: 20097189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
    Milatovic D; Moretto A; Osman KA; Lotti M
    Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic interactions of a neuropathy potentiator (phenylmethylsulfonyl fluoride) with the neuropathy target esterase and other membrane bound esterases.
    Mangas I; Vilanova E; Estévez J
    Arch Toxicol; 2014 Feb; 88(2):355-66. PubMed ID: 24071788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
    Moretto A; Bertolazzi M; Lotti M
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of carboxylesterases of chicken neural tissue by inhibition with a neuropathic, non-neuropathic organophosphorus compounds and neuropathy promoter.
    Céspedes MV; Escudero MA; Barril J; Sogorb MA; Vicedo JL; Vilanova E
    Chem Biol Interact; 1997 Oct; 106(3):191-200. PubMed ID: 9413546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens.
    Moretto A; Nicolli A; Lotti M
    Chem Biol Interact; 2005 Dec; 157-158():285-91. PubMed ID: 16243301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors.
    Lotti M; Moretto A
    Chem Biol Interact; 1999 May; 119-120():519-24. PubMed ID: 10421491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and selectivity of compounds interacting with neuropathy target esterase. Further structure-activity studies.
    Johnson MK
    Biochem Pharmacol; 1988 Nov; 37(21):4095-104. PubMed ID: 3190748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY; Casida JE
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity.
    Quesada E; Sogorb MA; Vilanova E; Carrera V
    Toxicol Lett; 2004 Jun; 151(1):163-70. PubMed ID: 15177651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.
    Lotti M; Caroldi S; Capodicasa E; Moretto A
    Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of neuropathy inducers and potentiators/promoters with soluble esterases.
    Estévez J; Mangas I; Sogorb MÁ; Vilanova E
    Chem Biol Interact; 2013 Mar; 203(1):245-50. PubMed ID: 23200747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
    Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylmethylsulfonyl fluoride, a potentiator of neuropathy, alters the interaction of organophosphorus compounds with soluble brain esterases.
    Mangas I; Vilanova E; Estévez J
    Chem Res Toxicol; 2012 Nov; 25(11):2393-401. PubMed ID: 23009703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride.
    Pope CN; Padilla S
    J Toxicol Environ Health; 1990 Dec; 31(4):261-73. PubMed ID: 2254952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inhibition of neuropathy target esterase in mouse nervous tissues in vitro on phosphatidylcholine and lysophosphatidylcholine homeostasis.
    Hou WY; Long DX; Wu YJ
    Int J Toxicol; 2009; 28(5):417-24. PubMed ID: 19620706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens.
    Hou WY; Long DX; Wang HP; Wang Q; Wu YJ
    Toxicology; 2008 Oct; 252(1-3):56-63. PubMed ID: 18755237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition by mipafox of soluble and particulate forms of organophosphorus neuropathy target esterase (NTE) in hen sciatic nerve.
    Carrera V; Díaz-Alejo N; Sogorb MA; Vicedo JL; Vilanova E
    Toxicol Lett; 1994 Mar; 71(1):47-51. PubMed ID: 8140588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTE and non-NTE esterases in brain membrane: kinetic characterization with organophosphates.
    Mangas I; Vilanova E; Estévez J
    Toxicology; 2012 Jul; 297(1-3):17-25. PubMed ID: 22503708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.